|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:36343453 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
affects binding |
ISO |
Auranofin analog binds to ALB protein |
CTD |
PMID:16791640 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
multiple interactions increases response to substance |
ISO |
[BAX co-treated with BAK1] results in increased susceptibility to Auranofin; BAK1 mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein] BAK1 results in increased susceptibility to Auranofin |
CTD |
PMID:18789312 PMID:21172426 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases response to substance |
ISO |
[BAX co-treated with BAK1] results in increased susceptibility to Auranofin; BAX mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein] BAX results in increased susceptibility to Auranofin |
CTD |
PMID:18789312 PMID:21172426 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO |
BCL2 protein inhibits the reaction [Auranofin results in increased activity of CASP3 protein] |
CTD |
PMID:18789312 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO EXP |
Auranofin promotes the reaction [TNF protein results in increased activity of CASP3 protein]; Auranofin results in decreased expression of and results in increased cleavage of CASP3 protein; BCL2 protein inhibits the reaction [Auranofin results in increased activity of CASP3 protein] BAK1 mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein]; BAX mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein] |
CTD |
PMID:15159275 PMID:15191400 PMID:18789312 PMID:20542334 PMID:21699084 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
Auranofin results in decreased expression of and results in increased cleavage of CASP8 protein |
CTD |
PMID:20542334 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
Auranofin results in decreased expression of and results in increased cleavage of CASP9 protein |
CTD |
PMID:20542334 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
Auranofin results in increased expression of CDKN1A protein |
CTD |
PMID:20542334 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cebpe |
CCAAT/enhancer binding protein epsilon |
multiple interactions |
ISO |
[Auranofin co-treated with Tretinoin] results in increased expression of CEBPE protein |
CTD |
PMID:15159275 |
|
NCBI chr15:28,169,711...28,171,471
Ensembl chr15:28,169,704...28,171,814
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
multiple interactions |
ISO |
Auranofin inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CHUK protein]; Auranofin inhibits the reaction [Lipopolysaccharides results in increased activity of CHUK protein] Auranofin inhibits the reaction [TNF protein results in increased activity of CHUK protein] |
CTD |
PMID:10820281 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Dio1 |
iodothyronine deiodinase 1 |
decreases activity |
ISO |
Auranofin results in decreased activity of DIO1 protein |
CTD |
PMID:34662569 |
|
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased expression of and results in increased secretion of EGF protein] |
CTD |
PMID:36343453 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions increases expression |
ISO |
[Peptidoglycan co-treated with Lipopolysaccharides] promotes the reaction [Auranofin results in increased expression of GPX1 protein]; Auranofin promotes the reaction [[Lipopolysaccharides co-treated with Peptidoglycan] results in increased expression of GPX1 protein] |
CTD |
PMID:21355852 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased activity of GSR protein] |
CTD |
PMID:36343453 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
Auranofin results in increased expression of HMOX1 mRNA Auranofin results in increased expression of HMOX1 mRNA; Auranofin results in increased expression of HMOX1 protein |
CTD |
PMID:22008538 PMID:23942037 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Auranofin inhibits the reaction [IL1B protein affects the localization of RELA protein]; Auranofin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; Auranofin inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] |
CTD |
PMID:10594346 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
[Auranofin co-treated with IL6 protein] results in decreased phosphorylation of IL6ST protein; [Auranofin co-treated with IL6 protein] results in decreased phosphorylation of JAK2 protein; [Auranofin co-treated with IL6 protein] results in decreased phosphorylation of STAT3 protein |
CTD |
PMID:20542334 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6st |
interleukin 6 cytokine family signal transducer |
multiple interactions |
ISO |
[Auranofin co-treated with IL6 protein] results in decreased phosphorylation of IL6ST protein |
CTD |
PMID:20542334 |
|
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
multiple interactions |
ISO |
Auranofin inhibits the reaction [lipopolysaccharide A results in increased degradation of IRAK1 protein] |
CTD |
PMID:17034761 |
|
NCBI chr X:151,768,621...151,778,521
Ensembl chr X:151,768,777...151,778,521
|
|
G |
Irf3 |
interferon regulatory factor 3 |
multiple interactions |
ISO |
Auranofin inhibits the reaction [lipopolysaccharide A results in increased activity of IRF3 protein]; Auranofin inhibits the reaction [lipopolysaccharide A results in increased phosphorylation of IRF3 protein]; Auranofin inhibits the reaction [TBK1 protein results in increased activity of IRF3 protein]; Auranofin inhibits the reaction [TICAM1 protein results in increased activity of IRF3 protein] |
CTD |
PMID:17034761 |
|
NCBI chr 1:95,479,966...95,484,926
Ensembl chr 1:95,479,821...95,484,935
|
|
G |
Itgam |
integrin subunit alpha M |
multiple interactions |
ISO |
[Auranofin co-treated with Tretinoin] results in increased expression of ITGAM protein |
CTD |
PMID:15159275 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Jak2 |
Janus kinase 2 |
multiple interactions |
ISO |
[Auranofin co-treated with IL6 protein] results in decreased phosphorylation of JAK2 protein |
CTD |
PMID:20542334 |
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:36343453 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:36343453 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:36343453 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
multiple interactions decreases expression |
ISO |
[Auranofin co-treated with SN50 peptide] results in decreased expression of MCL1 protein Auranofin results in decreased expression of MCL1 protein |
CTD |
PMID:20542334 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased expression of NFE2L2 protein] |
CTD |
PMID:36343453 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
Auranofin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein] |
CTD |
PMID:10820281 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfkbib |
NFKB inhibitor beta |
multiple interactions |
ISO |
Auranofin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIB protein] |
CTD |
PMID:10820281 |
|
NCBI chr 1:84,046,292...84,053,862
Ensembl chr 1:84,046,295...84,053,862
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
decreases activity increases cleavage |
ISO |
Auranofin results in decreased activity of PARP1 protein Auranofin results in increased cleavage of PARP1 protein |
CTD |
PMID:15159275 PMID:21370912 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Ppif |
peptidylprolyl isomerase F |
increases oxidation multiple interactions |
ISO EXP |
Auranofin results in increased oxidation of PPIF protein Auranofin inhibits the reaction [[NADP co-treated with TXNRD1 protein] results in increased activity of PPIF protein]; Cyclosporine promotes the reaction [Auranofin results in increased oxidation of PPIF protein] |
CTD |
PMID:26975474 |
|
NCBI chr16:1,257,197...1,263,919
Ensembl chr16:1,257,106...1,263,913
|
|
G |
Prdx3 |
peroxiredoxin 3 |
increases oxidation multiple interactions |
ISO EXP |
Auranofin results in increased oxidation of PRDX3 protein Cyclosporine promotes the reaction [Auranofin results in increased oxidation of PRDX3 protein] Auranofin promotes the reaction [[Lipopolysaccharides co-treated with Peptidoglycan] results in increased expression of PRDX3 protein] |
CTD |
PMID:18789312 PMID:21355852 PMID:26975474 |
|
NCBI chr 1:260,001,642...260,014,064
Ensembl chr 1:260,001,637...260,014,111
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
[lipopolysaccharide A co-treated with Auranofin] results in decreased expression of PTGS2 protein Auranofin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; Auranofin inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] |
CTD |
PMID:10594346 PMID:17034761 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases phosphorylation |
ISO |
Auranofin results in decreased phosphorylation of RB1 protein |
CTD |
PMID:20542334 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rbms3 |
RNA binding motif, single stranded interacting protein 3 |
affects response to substance |
ISO |
RBMS3 protein affects the susceptibility to Auranofin |
CTD |
PMID:36414028 |
|
NCBI chr 8:116,305,227...117,625,730
Ensembl chr 8:116,309,882...117,625,423
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Auranofin inhibits the reaction [IL1B protein affects the localization of RELA protein]; Auranofin promotes the reaction [arsenite results in increased phosphorylation of RELA protein] |
CTD |
PMID:10594346 PMID:36343453 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
increases response to substance |
ISO |
HLA-DQA1 gene polymorphism results in increased susceptibility to Auranofin |
CTD |
PMID:11436868 |
|
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
increases response to substance |
ISO |
HLA-DRB1 gene polymorphism results in increased susceptibility to Auranofin |
CTD |
PMID:11436868 |
|
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Auranofin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
decreases expression multiple interactions |
ISO |
Auranofin results in decreased expression of STAT3 protein modified form [Auranofin co-treated with IL6 protein] results in decreased phosphorylation of STAT3 protein |
CTD |
PMID:20542334 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tbk1 |
TANK-binding kinase 1 |
multiple interactions |
ISO |
Auranofin inhibits the reaction [TBK1 protein results in increased activity of IRF3 protein] |
CTD |
PMID:17034761 |
|
NCBI chr 7:57,077,830...57,110,868
Ensembl chr 7:57,077,830...57,110,892
|
|
G |
Tgfa |
transforming growth factor alpha |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased expression of and results in increased secretion of TGFA protein] |
CTD |
PMID:36343453 |
|
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
|
|
G |
Ticam1 |
TIR domain containing adaptor molecule 1 |
multiple interactions |
ISO |
Auranofin inhibits the reaction [TICAM1 protein results in increased activity of IRF3 protein] |
CTD |
PMID:17034761 |
|
NCBI chr 9:1,102,559...1,111,023
Ensembl chr 9:1,102,366...1,123,147
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
Auranofin inhibits the reaction [lipopolysaccharide A promotes the reaction [TLR4 protein binds to TLR4 protein]] |
CTD |
PMID:17034761 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Auranofin inhibits the reaction [TNF protein results in increased activity of CHUK protein]; Auranofin promotes the reaction [TNF protein results in increased activity of CASP3 protein] Auranofin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] |
CTD |
PMID:10820281 PMID:18789312 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Txn1 |
thioredoxin 1 |
increases oxidation multiple interactions |
ISO |
Auranofin results in increased oxidation of TXN protein Auranofin inhibits the reaction [arsenite results in increased expression of TXN protein] |
CTD |
PMID:26975474 PMID:36343453 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Txn2 |
thioredoxin 2 |
increases oxidation multiple interactions |
ISO EXP |
Auranofin results in increased oxidation of TXN2 protein Cyclosporine promotes the reaction [Auranofin results in increased oxidation of TXN2 protein] |
CTD |
PMID:26975474 |
|
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
multiple interactions decreases activity increases oxidation increases expression |
ISO EXP |
Auranofin inhibits the reaction [arsenite results in increased expression of and results in increased activity of TXNRD1 protein]; Auranofin inhibits the reaction [Sodium Selenite results in increased activity of TXNRD1 protein]; Auranofin promotes the reaction [Sodium Selenite results in increased expression of TXNRD1 mRNA]; potassium tellurate(IV) promotes the reaction [Auranofin results in increased oxidation of TXNRD1 protein]; Sodium Selenite promotes the reaction [Auranofin results in increased oxidation of TXNRD1 protein] Auranofin inhibits the reaction [[NADP co-treated with TXNRD1 protein] results in increased activity of PPIF protein]; Auranofin inhibits the reaction [[TXNRD1 protein co-treated with NADP] results in increased abundance of Superoxides] Auranofin results in decreased activity of TXNRD1 protein Auranofin results in increased expression of TXNRD1 mRNA |
CTD |
PMID:16510263 PMID:18405881 PMID:18789312 PMID:19486940 PMID:20457604 PMID:21172426 PMID:26975474 PMID:36343453 More...
|
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
multiple interactions decreases activity |
ISO EXP |
Auranofin inhibits the reaction [Sodium Selenite results in increased activity of TXNRD2 protein]; Auranofin promotes the reaction [Sodium Selenite results in decreased expression of TXNRD2 mRNA] Auranofin results in decreased activity of TXNRD2 protein |
CTD |
PMID:15458826 PMID:19486940 PMID:21172426 PMID:21355852 |
|
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
|
|
|
G |
Ackr3 |
atypical chemokine receptor 3 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of ACKR3 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
|
|
G |
Adora2a |
adenosine A2a receptor |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of ADORA2A mRNA |
CTD |
PMID:19192274 |
|
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of AMIGO2 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
|
|
G |
Antxr1 |
ANTXR cell adhesion molecule 1 |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of ANTXR1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 4:119,590,770...119,778,232
Ensembl chr 4:119,590,771...119,778,232
|
|
G |
Aox1 |
aldehyde oxidase 1 |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of AOX1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of BCL2A1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of BST2 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of CCL20 mRNA; Gold Sodium Thiomalate results in decreased expression of CCL20 protein |
CTD |
PMID:19192274 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccn1 |
cellular communication network factor 1 |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of CCN1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccn5 |
cellular communication network factor 5 |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of CCN5 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 3:152,491,247...152,502,639
Ensembl chr 3:152,491,220...152,502,636
|
|
G |
Cd28 |
Cd28 molecule |
multiple interactions affects response to substance |
ISO |
CD28 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein] CD28 protein affects the susceptibility to Gold Sodium Thiomalate |
CTD |
PMID:19077085 |
|
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
multiple interactions |
ISO |
Gold Sodium Thiomalate inhibits the reaction [Lipopolysaccharides results in increased activity of CHUK protein] |
CTD |
PMID:10820281 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Clgn |
calmegin |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of CLGN mRNA |
CTD |
PMID:19192274 |
|
NCBI chr19:24,695,140...24,728,542
Ensembl chr19:24,696,875...24,728,758
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of COL1A1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Colec12 |
collectin sub-family member 12 |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of COLEC12 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of CXCL1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of CXCL2 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of CXCL1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of CXCR4 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Ddx10 |
DEAD-box helicase 10 |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of DDX10 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 8:53,488,656...53,643,373
Ensembl chr 8:53,488,656...53,643,373
|
|
G |
Dio1 |
iodothyronine deiodinase 1 |
decreases activity |
ISO |
Gold Sodium Thiomalate results in decreased activity of DIO1 protein |
CTD |
PMID:34662569 |
|
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of EFEMP1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of ENPP2 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
|
|
G |
Entpd3 |
ectonucleoside triphosphate diphosphohydrolase 3 |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of ENTPD3 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 8:120,246,412...120,277,943
Ensembl chr 8:120,247,121...120,277,943
|
|
G |
Fbl |
fibrillarin |
affects localization multiple interactions decreases activity |
ISO |
Gold Sodium Thiomalate affects the localization of FBL protein CD28 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]; IFNG protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]; IL4 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]; IL6 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein] |
CTD |
PMID:10942594 PMID:19077085 |
|
NCBI chr 1:83,469,832...83,478,932
Ensembl chr 1:83,469,832...83,478,932
|
|
G |
Fbln1 |
fibulin 1 |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of FBLN1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of FGF7 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
|
|
G |
Gbp1 |
guanylate binding protein 1 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of GBP1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
|
|
G |
Gpm6b |
glycoprotein m6b |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of GPM6B mRNA |
CTD |
PMID:19192274 |
|
NCBI chr X:28,057,788...28,204,409
Ensembl chr X:28,059,450...28,204,211
|
|
G |
Gsdme |
gasdermin E |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of GSDME mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 4:79,258,799...79,321,129
Ensembl chr 4:79,257,804...79,320,806
|
|
G |
Herc6 |
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of HERC6 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 4:87,524,470...87,566,895
Ensembl chr 4:87,524,493...87,581,744
|
|
G |
Hilpda |
hypoxia inducible lipid droplet-associated |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of HILPDA mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of HSD11B1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
|
|
G |
Ifi27 |
interferon, alpha-inducible protein 27 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of IFI27 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
|
|
G |
Ifi35 |
interferon-induced protein 35 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of IFI35 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
|
|
G |
Ifi44 |
interferon-induced protein 44 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of IFI44 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 2:240,626,058...240,643,879
Ensembl chr 2:240,626,066...240,643,844
|
|
G |
Ifi44l |
interferon-induced protein 44-like |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of IFI44L mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
|
|
G |
Ifih1 |
interferon induced with helicase C domain 1 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of IFIH1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
|
|
G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of IFIT3 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
|
|
G |
Ifng |
interferon gamma |
multiple interactions affects response to substance |
ISO |
IFNG protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein] IFNG protein affects the susceptibility to Gold Sodium Thiomalate |
CTD |
PMID:19077085 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
ISO |
Gold Sodium Thiomalate inhibits the reaction [Lipopolysaccharides results in increased activity of IKBKB protein] |
CTD |
PMID:10820281 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
[Gold Sodium Thiomalate co-treated with mercury nitrate analog] results in increased expression of IL10 protein |
CTD |
PMID:11824965 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Gold Sodium Thiomalate inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Gold Sodium Thiomalate inhibits the reaction [IL1B protein results in increased expression of PTGES] |
CTD |
PMID:16393772 PMID:25314295 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of IL1RN mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il23a |
interleukin 23 subunit alpha |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of IL23A mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
|
|
G |
Il4 |
interleukin 4 |
multiple interactions affects response to substance |
ISO |
IL4 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein] IL4 protein affects the susceptibility to Gold Sodium Thiomalate |
CTD |
PMID:19077085 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
multiple interactions affects response to substance decreases expression |
ISO |
[Gold Sodium Thiomalate co-treated with mercury nitrate analog] results in increased expression of IL6 protein IL6 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein] IL6 protein affects the susceptibility to Gold Sodium Thiomalate Gold Sodium Thiomalate results in decreased expression of IL6 mRNA; Gold Sodium Thiomalate results in decreased expression of IL6 protein |
CTD |
PMID:11824965 PMID:19077085 PMID:19192274 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Irf7 |
interferon regulatory factor 7 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of IRF7 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
|
|
G |
Isg15 |
ISG15 ubiquitin-like modifier |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of ISG15 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
|
|
G |
Isg20 |
interferon stimulated exonuclease gene 20 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of ISG20 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
|
|
G |
Lamb3 |
laminin subunit beta 3 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of LAMB3 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405
|
|
G |
Lxn |
latexin |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of LXN mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 2:151,727,556...151,733,426
Ensembl chr 2:151,727,102...151,733,460
|
|
G |
Ly6e |
lymphocyte antigen 6 family member E |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of LY6E mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 7:106,935,530...106,939,689
Ensembl chr 7:106,935,761...106,939,689
|
|
G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of MARCKS mRNA |
CTD |
PMID:19192274 |
|
NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of MET mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Mir99b |
microRNA 99b |
multiple interactions |
ISO |
Gold Sodium Thiomalate inhibits the reaction [Lipopolysaccharides results in increased expression of MIR99B mRNA] |
CTD |
PMID:33109608 |
|
NCBI chr 1:58,677,015...58,677,084
Ensembl chr 1:58,677,011...58,677,090
|
|
G |
Mmp10 |
matrix metallopeptidase 10 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of MMP10 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
|
|
G |
Mx1 |
MX dynamin like GTPase 1 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of MX1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
|
|
G |
Ndufa4l2 |
NDUFA4, mitochondrial complex associated like 2 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of NDUFA4L2 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 7:63,351,021...63,359,010
Ensembl chr 7:63,356,883...63,359,010
|
|
G |
Nmb |
neuromedin B |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of NMB mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 1:134,869,446...134,875,507
Ensembl chr 1:134,869,446...134,872,190
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
Gold Sodium Thiomalate inhibits the reaction [[IL1B protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] |
CTD |
PMID:16393772 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of NR4A3 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 5:62,361,588...62,401,489
Ensembl chr 5:62,361,822...62,402,733
|
|
G |
Oas1a |
2'-5' oligoadenylate synthetase 1A |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of OAS1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr12:35,669,798...35,680,505
Ensembl chr12:35,669,801...35,680,517
|
|
G |
Oasl |
2'-5'-oligoadenylate synthetase-like |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of OASL mRNA |
CTD |
PMID:19192274 |
|
NCBI chr12:41,682,900...41,695,641
Ensembl chr12:41,682,900...41,695,641
|
|
G |
Olfml2b |
olfactomedin-like 2B |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of OLFML2B mRNA |
CTD |
PMID:19192274 |
|
NCBI chr13:82,869,414...82,906,607
Ensembl chr13:82,869,433...82,906,607
|
|
G |
Phgdh |
phosphoglycerate dehydrogenase |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of PHGDH mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
|
|
G |
Plpp3 |
phospholipid phosphatase 3 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of PLPP3 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205
|
|
G |
Ppp4r2 |
protein phosphatase 4, regulatory subunit 2 |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of PPP4R2 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 4:133,454,555...133,495,486
Ensembl chr 4:133,454,555...133,495,486
|
|
G |
Ptges |
prostaglandin E synthase |
multiple interactions |
ISO |
Gold Sodium Thiomalate inhibits the reaction [IL1B protein results in increased expression of PTGES] |
CTD |
PMID:25314295 |
|
NCBI chr 3:14,177,892...14,189,236
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of PTGS2 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rarres1 |
retinoic acid receptor responder 1 |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of RARRES1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 2:151,749,715...151,783,975
Ensembl chr 2:151,749,715...151,783,978
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Gold Sodium Thiomalate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein] |
CTD |
PMID:33109608 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rgs4 |
regulator of G-protein signaling 4 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of RGS4 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr13:81,936,775...81,943,103
Ensembl chr13:81,936,775...81,943,068
|
|
G |
Rig1 |
RNA sensor RIG-1 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of RIGI mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:55,321,235...55,370,819
|
|
G |
Ripk2 |
receptor-interacting serine-threonine kinase 2 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of RIPK2 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:29,631,570...29,662,657
|
|
G |
Rnf19b |
ring finger protein 19B |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of RNF19B mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 5:141,406,085...141,431,376
Ensembl chr 5:141,406,118...141,431,380
|
|
G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of RSAD2 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of SLC7A11 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Sms |
spermine synthase |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of SMS mRNA |
CTD |
PMID:19192274 |
|
NCBI chr X:37,516,949...37,572,657
Ensembl chr X:37,516,931...37,570,822
|
|
G |
Sod2 |
superoxide dismutase 2 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of SOD2 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Spon1 |
spondin 1 |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of SPON1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of STAT1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Sts |
steroid sulfatase |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of STS mRNA |
CTD |
PMID:19192274 |
|
NCBI chr X:42,225,131...42,233,403
Ensembl chr X:42,225,372...42,233,402
|
|
G |
Thbs1 |
thrombospondin 1 |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of THBS1 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
|
|
G |
Thbs2 |
thrombospondin 2 |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of THBS2 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 1:55,670,394...55,699,789
Ensembl chr 1:55,670,394...55,699,789
|
|
G |
Tlr2 |
toll-like receptor 2 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of TLR2 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tnfaip2 |
TNF alpha induced protein 2 |
decreases expression |
ISO |
Gold Sodium Thiomalate results in decreased expression of TNFAIP2 mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 6:130,476,832...130,489,914
Ensembl chr 6:130,476,889...130,489,914
|
|
G |
Txnip |
thioredoxin interacting protein |
increases expression |
ISO |
Gold Sodium Thiomalate results in increased expression of TXNIP mRNA |
CTD |
PMID:19192274 |
|
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
multiple interactions decreases activity |
ISO EXP |
Gold Sodium Thiomalate inhibits the reaction [TXNRD1 protein affects the metabolism of Dithionitrobenzoic Acid] Gold Sodium Thiomalate results in decreased activity of TXNRD1 protein |
CTD |
PMID:16510263 PMID:17229725 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
decreases activity |
EXP |
Gold Sodium Thiomalate results in decreased activity of TXNRD2 protein |
CTD |
PMID:15458826 |
|
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
|
|
|
G |
Alb |
albumin |
affects binding |
ISO |
Gold Sodium Thiosulfate binds to ALB protein |
CTD |
PMID:16791640 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Cd40 |
CD40 molecule |
increases expression |
ISO |
Gold Sodium Thiosulfate results in increased expression of CD40 protein |
CTD |
PMID:25458486 |
|
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Il6 |
interleukin 6 |
increases secretion |
ISO |
Gold Sodium Thiosulfate results in increased secretion of IL6 protein |
CTD |
PMID:25458486 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Tlr3 |
toll-like receptor 3 |
multiple interactions |
ISO |
TLR3 protein affects the reaction [Gold Sodium Thiosulfate results in increased secretion of CXCL8 protein] |
CTD |
PMID:25458486 |
|
NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545
|
|